ABSTRACT
Introduction
During the last few decades, the development of new techniques to provide central vascular access has been a revolutionary step in the care of critically ill neonates and children. Unfortunately, the use of central vascular catheters (CVCs) is associated with the risk of central line-associated bloodstream infections (CLABSIs), caused by microorganisms that colonize the implanted device or contaminate the fluid pathway. (1) CLABSIs are the single most important cause of health care-associated infections in neonatal (NICU) and pediatric intensive care units (PICU) (2) (3) (4) (5) (6) (7) and are associated with increased morbidity, hospital lenght of stay, and health care costs. (8) Several factors have been reported in critically ill neonates and children as being associated with an increased CLABSI rate, including the presence of multiple CVCs, (4) the total duration of CVC use, (4, 6) administration of parenteral nutrition, packed red blood cell transfusions, (5, 6 ) and the use of extracorporeal membrane oxygenation (ECMO). (4) Patient-related factors have also been reported to increase the risk for CLABSI, including age (neonates), birthweight, gastrointestinal diagnoses, oncologic diagnoses, and cardiac surgery. (2, 6, 7, 9) The various types of CVCs are associated with different risks of CLABSI in adults. (10) Although it is generally acknowledged that the same principle applies for pediatric population, the magnitude of variability in CLABSI rate with different types of CVCs in critically ill neonates and children is largely unknown. Recently, a study of CLABSI rates in all children under care in a children's hospital (intensive care, general wards, out-patient setting) identified the highest risk of CLABSI in neonates with peripherally inserted central venous catheters (PICCs) and the lowest risk in children with totally implanted CVCs (Porth-a-cath). (11) However, most of these patients were not critically ill. Patients being cared for in a multidisciplinary neonatal and pediatric ICU probably have a different CLABSI risk profile. Few data exist regarding CLABSI rates with different types of CVCs in multidisciplinary PICUs. (4) The goal of this study was therefore to prospectively assess the current burden of CLABSI in our multidisciplinary neonatal and pediatric ICU and to identify the CLABSI rate associated with different types of CVCs.
Materials and methods
This was a prospective study in a level III multidisciplinary 14- 
Results
A total of 557 admissions to the PICU were identified during the 14-month study period from January 1 st 2011 to February 29 th 2012, of whom 258 were medical and 299 were surgical. A total of 362 admissions (65 %) involved the use of 1 or more CVCs. The mean age of the population was 2.7 years (range few hours -18 years). A total of 457 (82 %) admissions required mechanical ventilation and 161 (29 %) required vasopressor/inotropic support. During the study period 26 (4.7 %) patients died, of whom 11 were medical and 15 surgical patients. We identified a total of 4259 patientdays, 3225 catheter-days (CVC utilization ratio 0.76) and 14 episodes of CLABSI with an overall CLABSI rate of 4.3/1000 catheter-days in our PICU. The use and duration of use for different types of CVCs is shown in table 1. The crude risk for development of CLAB-SI, risk ratio for CLABSI and CLABSI rate per 1000 catheter-days by different types of CVCs are shown in table 2. We did not detect any episode of CLABSI associated with use of umbilical catheters. We used short-term noncuffed and nontunneled CVCs as a reference group for bivariate associations between the use of different types of CVCs and the risk of CLABSI. Patients that required RRT CVCs had 12.9-fold increased risk for developing CLABSI compared with the reference group of patients (p<0.001, Pearson's chi-square test). Patients with long-term cuffed, tunneled CVCs and PICCs had 1.8-and 1.9-fold increased risk, respectively, for developing CLABSI as compared with the reference group of patients, but this increased risk was not statistically significant. We identified a total of 27 patients and 254 catheter-days with multiple (ě 2) CVCs in place at one time. Five of 14 children (35 %) with CLABSI had multiple CVCs in place at the time of CLABSI. The use of multiple CVCs at the same time was associated with a crude risk for CLABSI of 18.5% and with a 5.7-fold increase in the risk of developing CLAB-SI compared with the reference group of patients with only one CVC in place at one time (95% confidence interval (CI): 1.5-24.0). This increased risk was statistically significant (p<0.001, Pearson's chi-square test). CLABSI rate expressed per 1000 catheter-days was 19.7 and 3.0 in association with the use of multiple CVCs or single CVC at the same time, respectively.
Discussion
In this study, CLABSI rate of 4.3 per 1000 catheter-days was established in our multidisciplinary neonatal and pediatric ICU. This overall CLABSI rate compares favourably with some studies in PICUs that reported rates up to 20.6 per 1000 catheter-days, (13) (14) (15) but is higher than the pooled mean rate of 3.0 per 1000 catheter-days for medical/surgical PICUs reporting to the CDC/NHSN system. (9) The higher CLABSI rate in our study could be attributable to the large proportion of neonates, including extremely premature neonates, in our PICU that are known to be at highest risk for CLABSI. (9) Furthermore, a high percentage of our patients are neonates and children undergoing complex cardiac surgery that are also known to have higher CLABSI rates, partly because of extensive use of invasive devices. (9,16) Accordingly, in a multicenter study that included multidisciplinary as well as dedicated cardiac PICUs, CLABSI rate was the same as in our study. (17) Short-term noncuffed and nontunneled CVCs are the most prevalent type of CVC used in our unit (70% of catheter-days) and therefore accounted for the majority of CLABSIs (50%) in our study. However, when CLABSI rate was expressed per 1000 catheter-days, short-term noncuffed and nontunneled CVCs had a CLABSI rate of 3.1, which was lower than the rate for long-term cuffed, tunneled CVCs, RRT CVCs and PICCs, but considerably higher than the CLABSI rate for umbilical catheters. We observed the highest CLABSI rate of 20.0 per 1000-catheter days in RRT CVCs. Patients that required RRT CVC had a 12.9-fold increased risk for developing CLABSI compared to patients with short-term noncuffed and nontunneled CVCs. Our results are consistent with the study by Odetola et al. that also observed an increased risk of developing CLABSI in PICU patients requiring RRT CVC. (4) The observed increase in CLABSI risk in neonates and children requiring RRT has a number of intuitive pathophysiologic explanations. First, these patients are exposed to immunosuppressive effects of extracorporeal circulation. The initial response is mainly proinflammatory, followed by an anti- (7,27) Furthermore, bacterial translocation across the intestinal mucosa is also more frequent in patients with gastrointestinal diseases and may be attributed by default to a CVC when using the current CDC/NHSN surveillance definition for CLABSI. (7) For long-term central venous access, cuffed and tunneled CVCs are associated with a higher risk for CLABSI than totally implanted devices (Porth-a-cath). (10, 11, 28) . However, if the patient needs continuous access for many days or intermittent access day after day, a cuffed and tunneled CVC is preferable to a totally implanted device. (10) According to this, switching to Porth-a-cath CVCs would not be appropriate for long-term central venous access in our population of neonates with complex surgical intestinal diseases that currently receive longterm cuffed, tunneled CVCs. In our study PICCs, with a CLABSI rate of 8.8 per 1000 catheter-days, posed a 1.9-fold increased risk for CLABSI compared to short-term noncuffed and nontunneled CVCs. As PICCs are used exclusively in neonates in our unit, we looked at other studies of PICCs in critically ill neonates. The problem of an inadequate definition of CLABSI was recently addressed by several authors. (7, 35, 36) Despite these limitations, our study provides useful data that define the risk of CLABSI with the various types of CVCs in use in a multidisciplinary neonatal and pediatric ICU, at the present time.
Our data suggest that all types of CVCs pose significant but widely differing risk of CLABSI and that all CLABSI studies should include types of CVCs utilized.
We have identified that the use of RRT CVCs and multiple CVCs at the same time are associated with the highest risk for CLABSI in a multidisciplinary neonatal and pediatric ICU. Larger future studies will need to validate these predictors for CLABSI, controlling also for severity of illness and to determine how prevention strategies can target this high risk group of patients. One such intervention could be the use of a cuffed tunneled RRT CVC instead of noncuffed, nontunneled RRT CVC in critically ill neonates and children with acute renal failure. Although our center-specific CLABSI rates in general compared well to publish data, measures to further decrease the observed CLABSI rates should be achieved with strict adherence to CVC insertion and maintenance bundles. (37) Hopefully, these efforts will improve the safety and quality of care for critically ill neonates and children in our and other PICUs.
